Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome

JA Lee, JJ Duby, CS Cocanour - Clinical Toxicology, 2019 - Taylor & Francis
Objective: Current evidence supports symptom-triggered therapy for alcohol withdrawal
syndrome (AWS). Early, escalating therapy with benzodiazepines (BZD) appears to …

Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome.

JA Lee, JJ Duby, CS Cocanour - Clinical Toxicology (Philadelphia …, 2019 - europepmc.org
Objective: Current evidence supports symptom-triggered therapy for alcohol withdrawal
syndrome (AWS). Early, escalating therapy with benzodiazepines (BZD) appears to …

[PDF][PDF] Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome

JA Lee, JJ Duby, CS Cocanour - researchgate.net
Objective: Current evidence supports symptom-triggered therapy for alcohol withdrawal
syndrome (AWS). Early, escalating therapy with benzodiazepines (BZD) appears to …

Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome

JA Lee, JJ Duby, CS Cocanour - Clinical toxicology …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective: Current evidence supports symptom-triggered therapy for alcohol withdrawal
syndrome (AWS). Early, escalating therapy with benzodiazepines (BZD) appears to …

Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome.

JA Lee, JJ Duby, CS Cocanour - 2019 - cabidigitallibrary.org
Objective: Current evidence supports symptom-triggered therapy for alcohol withdrawal
syndrome (AWS). Early, escalating therapy with benzodiazepines (BZD) appears to …